Loading
Cystotech makes software that watches the camera image during a bladder examination and points out areas that may be cancer, to help doctors miss fewer tumours.
Cystotech, from Aarhus, Denmark, was started by clinicians from bladder cancer care and develops CystoAID, a real-time AI support tool for diagnostic cystoscopy that the company describes as device-agnostic, plug-and-play and run on the hospital's own premises, with the clinician remaining the decision-maker. A randomised study is testing whether AI-supported cystoscopy is non-inferior to standard white-light cystoscopy for detecting bladder cancer (NCT06780358). Its first registered cancer trial, NCT06780358, was posted on ClinicalTrials.gov in January 2025.
Shares Cystoscopy, blue-light imaging & TURBT, Bladder & urothelial cancer.
Shares Cystoscopy, blue-light imaging & TURBT, Bladder & urothelial cancer.
Shares Cystoscopy, blue-light imaging & TURBT, Bladder & urothelial cancer.
Shares Cystoscopy, blue-light imaging & TURBT, Bladder & urothelial cancer.
Shares Cystoscopy, blue-light imaging & TURBT, Bladder & urothelial cancer.
Shares Cystoscopy, blue-light imaging & TURBT, Bladder & urothelial cancer.
Shares Cystoscopy, blue-light imaging & TURBT, Bladder & urothelial cancer.
Shares Cystoscopy, blue-light imaging & TURBT, Bladder & urothelial cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/